Thomas Sferra, MD

Showing of 2 results

UH Rainbow Gastroenterology Chief Plays Pivotal Role in FDA Approval of C. difficile Drug in Kids

Clinical trial results support extrapolation to the pediatric population of bezlotoxumab efficacy and safety established in adults - Innovations in Pediatrics | Fall 2023

11/19/2023 By Thomas Sferra, MD and UH

New Trial at UH Rainbow Evaluating Treatment to Prevent Recurrent C difficile Infection in Children

UH Clinical Update - August 2018 The incidence of C. difficile infection is increasing in children. “We don’t have a good sense of why it’s on the rise in kids,” says Thomas Sferra, MD, Division Chief of Pediatric Gastroenterology at UH...

8/30/2018 By Thomas Sferra, MD

Results are loading...